1 Min Read
Oct 31 (Reuters) - Avinger Inc
* Avinger Inc says received 510(k) clearance from U.S. FDA for modifications to co’s pantheris lumivascular atherectomy system Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.